PRMT5 and familial pancreatic carcinoma: Alternatively, combining low concentrations of PRMT1 or PRMT5 inhibitors is well tolerated in mice and can synergically reduce growth and promote apoptosis in pancreatic cancer and DLBCL cancer cells (37).